1. Home
  2. MAIA vs OPHC Comparison

MAIA vs OPHC Comparison

Compare MAIA & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • OPHC
  • Stock Information
  • Founded
  • MAIA 2018
  • OPHC 2000
  • Country
  • MAIA United States
  • OPHC United States
  • Employees
  • MAIA N/A
  • OPHC N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • OPHC Major Banks
  • Sector
  • MAIA Health Care
  • OPHC Finance
  • Exchange
  • MAIA Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • MAIA 56.3M
  • OPHC 51.8M
  • IPO Year
  • MAIA 2022
  • OPHC N/A
  • Fundamental
  • Price
  • MAIA $1.70
  • OPHC $4.19
  • Analyst Decision
  • MAIA
  • OPHC
  • Analyst Count
  • MAIA 0
  • OPHC 0
  • Target Price
  • MAIA N/A
  • OPHC N/A
  • AVG Volume (30 Days)
  • MAIA 464.6K
  • OPHC 11.0K
  • Earning Date
  • MAIA 11-11-2025
  • OPHC 11-07-2025
  • Dividend Yield
  • MAIA N/A
  • OPHC N/A
  • EPS Growth
  • MAIA N/A
  • OPHC 6.01
  • EPS
  • MAIA N/A
  • OPHC 1.28
  • Revenue
  • MAIA N/A
  • OPHC $41,269,000.00
  • Revenue This Year
  • MAIA N/A
  • OPHC N/A
  • Revenue Next Year
  • MAIA N/A
  • OPHC N/A
  • P/E Ratio
  • MAIA N/A
  • OPHC $3.33
  • Revenue Growth
  • MAIA N/A
  • OPHC 36.79
  • 52 Week Low
  • MAIA $1.40
  • OPHC $3.53
  • 52 Week High
  • MAIA $3.48
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 58.76
  • OPHC 39.69
  • Support Level
  • MAIA $1.54
  • OPHC $4.21
  • Resistance Level
  • MAIA $1.78
  • OPHC $4.30
  • Average True Range (ATR)
  • MAIA 0.09
  • OPHC 0.05
  • MACD
  • MAIA 0.02
  • OPHC 0.00
  • Stochastic Oscillator
  • MAIA 75.00
  • OPHC 7.89

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: